Theratechnologies logo

Theratechnologies share price today

(THTX)

Theratechnologies share price is $2.03 & ₹174.19 as on 7 Jan 2025, 2.30 'hrs' IST

$2.03

0.17

(9.14%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Theratechnologies share price in Dollar and Rupees. Guide to invest in Theratechnologies stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Theratechnologies, along with analyst recommendations, forecasts, and comprehensive financials.

Theratechnologies share price movements

  • Today's Low: $1.92
    Today's High: $2.05

    Day's Volatility :6.21%

  • 52 Weeks Low: $1.08
    52 Weeks High: $2.58

    52 Weeks Volatility :58.14%

Theratechnologies Returns

PeriodTheratechnologies IncIndex (Russel 2000)
3 Months
53.72%
0.0%
6 Months
20.01%
0.0%
1 Year
-19.13%
0.0%
3 Years
-84.4%
-19.8%

Theratechnologies Key Statistics

in dollars & INR

Previous Close
$1.86
Open
$1.9
Today's High
$2.0471
Today's Low
$1.92
Market Capitalization
$83.9M
Today's Volume
$278.7K
52 Week High
$2.58
52 Week Low
$1.08
Revenue TTM
$84.3M
EBITDA
$14.4M
Earnings Per Share (EPS)
$-0.04
Profit Margin
-3.75%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1116.86%

How to invest in Theratechnologies from India?

It is very easy for Indian residents to invest directly in Theratechnologies from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Theratechnologies stock in both Indian Rupees (INR) and US Dollars (USD). Search for Theratechnologies or THTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Theratechnologies or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Theratechnologies shares which would translate to 0.423 fractional shares of Theratechnologies as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Theratechnologies, in just a few clicks!

Returns in Theratechnologies for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Theratechnologies investment value today

Current value as on today

₹91,483

Returns

₹8,517

(-8.52%)

Returns from Theratechnologies Stock

₹11,739 (-11.74%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Theratechnologies

180%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Theratechnologies on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 180% more investors are searching Theratechnologies in the last 30 days versus the previous period.

Global Institutional Holdings in Theratechnologies

  • Soleus Capital Management, L.P.

    10.44%

  • AIGH Capital Management, LLC

    8.10%

  • Nantahala Capital Management, LLC

    5.83%

  • Morgan Stanley - Brokerage Accounts

    4.90%

  • Advisor Group Holdings, Inc.

    0.32%

  • Cyndeo Wealth Partners LLC

    0.29%

Analyst Recommendation on Theratechnologies

Buy

    81%Buy

    18%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Theratechnologies(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Theratechnologies

What analysts predicted

Upside of 86.5%

Current:

$2.03

Target:

$3.79

Insights on Theratechnologies

  • Price Movement

    In the last 1 month, THTX stock has moved up by 31.0%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 22.01M → 22.6M (in $), with an average increase of 1.3% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 4 quarters, -2.75M → 3.09M (in $), with an average increase of 149.1% per quarter
  • THTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 41.0%
  • THTX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 139.2%
  • Price to Sales

    ForTHTX every $1 of sales, investors are willing to pay $1.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Theratechnologies Financials in INR & Dollars

FY18Y/Y Change
Revenue
$44.1M
↑ 32.59%
Net Income
$-4.5M
↓ 68.37%
Net Profit Margin
-10.27%
↑ 32.77%
FY19Y/Y Change
Revenue
$63.2M
↑ 43.49%
Net Income
$-12.5M
↑ 176.21%
Net Profit Margin
-19.77%
↓ 9.5%
FY20Y/Y Change
Revenue
$66.1M
↑ 4.49%
Net Income
$-22.7M
↑ 81.39%
Net Profit Margin
-34.32%
↓ 14.55%
FY21Y/Y Change
Revenue
$69.8M
↑ 5.71%
Net Income
$-31.7M
↑ 39.96%
Net Profit Margin
-45.44%
↓ 11.12%
FY22Y/Y Change
Revenue
$80.1M
↑ 14.66%
Net Income
$-47.2M
↑ 48.9%
Net Profit Margin
-59.0%
↓ 13.56%
FY23Y/Y Change
Revenue
$81.8M
↑ 2.13%
Net Income
$-24.0M
↓ 49.28%
Net Profit Margin
-29.3%
↑ 29.7%
Q2 FY23Q/Q Change
Revenue
$20.9M
↑ 4.76%
Net Income
$-746.0K
↓ 92.86%
Net Profit Margin
-3.58%
↑ 48.88%
Q3 FY23Q/Q Change
Revenue
$20.9M
↑ 0.0%
Net Income
$-746.0K
↑ 0.0%
Net Profit Margin
-3.58%
↑ 0.0%
Q4 FY23Q/Q Change
Revenue
$23.5M
↑ 12.45%
Net Income
$-2.8M
↑ 269.3%
Net Profit Margin
-11.75%
↓ 8.17%
Q1 FY24Q/Q Change
Revenue
$22.0M
↓ 6.15%
Net Income
$987.0K
↓ 135.83%
Net Profit Margin
4.48%
↑ 16.23%
Q2 FY24Q/Q Change
Revenue
$22.6M
↑ 2.68%
Net Income
$3.1M
↑ 213.17%
Net Profit Margin
13.68%
↑ 9.2%
Q3 FY24Q/Q Change
Revenue
$22.6M
↑ 0.0%
Net Income
$3.1M
↑ 0.0%
Net Profit Margin
13.68%
↑ 0.0%
FY18Y/Y Change
Profit
$29.4M
↑ 82.77%
FY19Y/Y Change
Profit
$37.1M
↑ 26.43%
FY20Y/Y Change
Profit
$39.2M
↑ 5.41%
FY21Y/Y Change
Profit
$46.6M
↑ 18.93%
FY22Y/Y Change
Profit
$53.8M
↑ 15.5%
FY23Y/Y Change
Profit
$62.1M
↑ 15.53%
Q2 FY23Q/Q Change
Profit
$15.9M
↑ 4.42%
Q3 FY23Q/Q Change
Profit
$15.9M
↑ 0.0%
Q4 FY23Q/Q Change
Profit
$18.4M
↑ 15.72%
Q1 FY24Q/Q Change
Profit
$17.1M
↓ 6.97%
Q2 FY24Q/Q Change
Profit
$18.1M
↑ 5.7%
Q3 FY24Q/Q Change
Profit
$18.1M
↑ 0.0%
FY18Y/Y Change
Operating Cash Flow
$-334.1K
↓ 117.55%
Investing Cash Flow
$-9.9M
↓ 52.23%
Financing Cash Flow
$46.8M
↑ 241.54%
FY19Y/Y Change
Operating Cash Flow
$-3.4M
↑ 915.09%
Investing Cash Flow
$-130.0K
↓ 98.69%
Financing Cash Flow
$-6.8M
↓ 114.53%
FY20Y/Y Change
Operating Cash Flow
$-13.6M
↑ 299.71%
Investing Cash Flow
$4.8M
↓ 3773.85%
Financing Cash Flow
$-7.2M
↑ 6.2%
FY21Y/Y Change
Operating Cash Flow
$-14.5M
↑ 6.81%
Investing Cash Flow
$-12.5M
↓ 360.76%
Financing Cash Flow
$37.9M
↓ 623.77%
FY22Y/Y Change
Operating Cash Flow
$-14.7M
↑ 1.49%
Investing Cash Flow
$8.7M
↓ 169.71%
Financing Cash Flow
$9.7M
↓ 74.5%
Q2 FY23Q/Q Change
Operating Cash Flow
$5.3M
↓ 259.6%
Investing Cash Flow
$734.0K
↑ 0.0%
Financing Cash Flow
$-7.9M
↑ 4785.19%
Q3 FY23Q/Q Change
Operating Cash Flow
$5.3M
↑ 0.0%
Investing Cash Flow
$558.0K
↓ 23.98%
Financing Cash Flow
$-7.9M
↑ 0.0%

Theratechnologies Technicals Summary

Sell

Neutral

Buy

Theratechnologies is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Theratechnologies Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Theratechnologies Inc
20.0%
20.01%
-19.13%
-84.4%
-82.25%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Theratechnologies Inc
NA
NA
NA
0.01
-11.17
0.12
NA
-0.43
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Theratechnologies Inc
Buy
$83.9M
-82.25%
NA
-3.75%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Theratechnologies

theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.
Organization
Theratechnologies
Employees
103
CEO
Mr. Paul Lévesque
Industry
Health Technology

Management People of Theratechnologies

NameTitle
Mr. Paul Lévesque
President, CEO & Director
Mr. Philippe Dubuc M.B.A., MBA
Senior VP & CFO
Mr. Jocelyn Lafond L.L.M., LL.B.
General Counsel & Corporate Secretary
Dr. Christian Marsolais Ph.D.
Senior VP & Chief Medical Officer
Mr. John Leasure
Global Commercial Officer
Hon. Andre Dupras M.Sc.
Vice President of Human Resources

Important FAQs about investing in Theratechnologies from India :

What is Theratechnologies share price today?

Theratechnologies share price today stands at $2.03, Open: $1.90 ; Previous Close: $1.86 ; High: $2.05 ; Low: $1.92 ; 52 Week High: $2.58 ; 52 Week Low: $1.08. The stock opens at $1.90, after a previous close of $1.86. The stock reached a daily high of $2.05 and a low of $1.92, with a 52-week high of $2.58 and a 52-week low of $1.08.

Can Indians buy Theratechnologies shares?

Yes, Indians can invest in the Theratechnologies (THTX) from India.

With INDmoney, you can buy Theratechnologies at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Theratechnologies at zero transaction cost.

How can I buy Theratechnologies shares from India?

It is very easy to buy Theratechnologies from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Theratechnologies be purchased?

Yes, you can buy fractional shares of Theratechnologies with INDmoney app.

What are the documents required to start investing in Theratechnologies stocks?

To start investing in Theratechnologies, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Theratechnologies

Today’s highest price of Theratechnologies (THTX) is $2.05.

Today’s lowest price of Theratechnologies (THTX) is $1.92.

What is today's market capitalisation of Theratechnologies

Today's market capitalisation of Theratechnologies THTX is 83.9M

What is the 52 Week High and Low Range of Theratechnologies

  • 52 Week High

    $2.58

  • 52 Week Low

    $1.08

What are the historical returns of Theratechnologies?

  • 1 Month Returns

    20%

  • 3 Months Returns

    20.01%

  • 1 Year Returns

    -19.13%

  • 5 Years Returns

    -82.25%

Who is the Chief Executive Officer (CEO) of Theratechnologies

Mr. Paul Lévesque is the current Chief Executive Officer (CEO) of Theratechnologies.